Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-04-06 | Mr. De Witte is Integra's President and Chief Executive Officer. He commenced service as President and Chief Executive Officer and a director in December 2021. |
| 2024-04-04 | Jan De Witte – President and Chief Executive Officer ... Age: 59 ... Director since: 2021 ... Committees: Finance ... No compensation listed for director role. |
| Filing Date | Source Excerpt |
|---|---|
| 2019-10-08 | Jan De Witte has served as ResMed’s director since May 2019, and is a member of its audit committee. ... Mr. De Witte’s skills and experience, particularly his over 20 years of experience in executive management, operations, and software operations; his position as a current operating CEO; and his international business experience, led the board to the conclusion that he should serve as a director. |
| 2020-10-06 | Jan De Witte has served as ResMed’s director since May 2019, and is a member of its audit and compliance oversight committee. ... Mr. De Witte’s skills and experience, particularly his over 20 years of experience in executive management, operations, and software operations; his position as a current operating CEO; and his international business experience, led the board to the conclusion that he should serve as a director. |
| 2021-10-06 | Jan De Witte has served as ResMed’s director since May 2019, and is a member of its audit and compliance oversight committees. ... Mr. De Witte is a global leader in services, solutions, and software business who over the past 30 years has served in a variety of operational and business leadership roles. ... Mr. De Witte holds a Master of Science degree in electromechanical engineering with Greatest Distinction from the KU Leuven in Belgium, and an MBA from Harvard Business School. ... Mr. De Witte’s skills and experience, particularly his 20-plus years of experience in executive management, operations, and software operations; his position as former operating CEO; and his international business experience led the board to the conclusion that he should serve as a director. |
| 2022-10-05 | Jan De Witte has served as a ResMed director since May 2019, and is a member of the audit and compliance oversight committees. ... Fiscal year 2022 director compensation table ... Jan De Witte $70,000 fees earned in cash, $249,975 option awards, total $319,975. |
| 2023-10-05 | Jan De Witte has served as a ResMed director since May 2019, and is a member of the audit and compliance oversight committees. ... Mr. De Witte’s skills and experience, particularly his 20-plus years of experience in executive management, operations, and software operations; his experience as an operating CEO in the field of medical technology; and his international business experience led the board to the conclusion that he should serve as a director. |
| 2024-10-03 | Jan De Witte | 60 Independent President and Chief Executive Officer of Integra Life Sciences Director since: 2019 Committees: Audit, Compliance Oversight |
Data sourced from SEC filings. Last updated: 2026-02-03